| Literature DB >> 22094250 |
Abstract
Constitutive activation of NF-κB signaling can promote oncogenesis, providing a rationale for anticancer strategies that inhibit NF-κB signaling. Two recent publications in Genes & Development provide evidence that, in contexts where prosurvival signals derive from other oncogenes, NF-κB activity instead enhances sensitivity to cytotoxic chemotherapy, thereby exerting a tumor-suppressor function. 2011 Elsevier Inc. All rights reserved.Entities:
Year: 2011 PMID: 22094250 PMCID: PMC3245902 DOI: 10.1016/j.ccr.2011.10.026
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743